The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
Open accessAbstract
The clinical course of autoimmune and infectious disease varies greatly, even between individuals with the same condition. An understanding of the molecular basis for this heterogeneity could lead to significant improvements in both monitoring and treatment. During chronic infection the process of T-cell exhaustion inhibits the immune response, facilitating viral persistence. Here we show that a transcriptional signature reflecting CD8 T-cell exhaustion is associated with poor clearance of chronic viral infection, but conversely predicts better prognosis in multiple autoimmune diseases. The development of CD8 T-cell exhaustion during chronic infection is driven both by persistence of antigen and by a lack of accessory 'help' signals. In autoimmunity, we find that where evidence of CD4 T-cell co-stimulation is pronounced, that of CD8 T-cell exhaustion is reduced. We can reproduce the exhaustion signature by modifying the balance of persistent stimulation of T-cell antigen receptors and specific CD2-induced co-stimulation provided to human CD8 T cells in vitro, suggesting that each process plays a role in dictating outcome in autoimmune disease. The 'non-exhausted' T-cell state driven by CD2-induced co-stimulation is reduced by signals through the exhaustion-associated inhibitory receptor PD-1, suggesting that induction of exhaustion may be a therapeutic strategy in autoimmune and inflammatory disease. Using expression of optimal surrogate markers of co-stimulation/exhaustion signatures in independent data sets, we confirm an association with good clinical outcome or response to therapy in infection (hepatitis C virus) and vaccination (yellow fever, malaria, influenza), but poor outcome in autoimmune and inflammatory disease (type 1 diabetes, anti-neutrophil cytoplasmic antibody-associated vasculitis, systemic lupus erythematosus, idiopathic pulmonary fibrosis and dengue haemorrhagic fever). Thus, T-cell exhaustion plays a central role in determining outcome in autoimmune disease and targeted manipulation of this process could lead to new therapeutic opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Consistently, a CD8 + Tcell transcriptional profile of exhaustion correlates with beneficial outcome in AID 35,59 and response to immunotherapies. 60”
From Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases (2024) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Emergence of Scaling in Random Networks
Barabási, A.-L., & Albert, R. (1999) · Science · doi:10.1126/science.286.5439.509 · Cited by 36,135
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,082
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Cited by
Sorted by citations
Items 201–300 of 692
Precision medicine in inflammatory bowel disease
Zeng, Z., Jiang, M., Li, X., Yuan, J., & Zhang, H. (2023) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbad033 · Cited by 43
“Ho w e v er, longer disease dur ation also r esults in v ery c hr onic inflammation and T cell exhaustion, indicating a good prognosis in c hr onic autoimm une disease [ 155 , 210 ].”
BackgroundEpigenetics and CD8+ T cell memory*
Montacchiesi, G., & Pace, L. (2021) · Immunological Reviews · doi:10.1111/imr.13057 · Cited by 43
Zhu, C., Dixon, K. O., Newcomer, K., Gu, G., Xiao, S., Zaghouani, S., Schramm, M. A., Wang, C., Zhang, H., Goto, K., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd2710 · Cited by 40
Landscapes and mechanisms of CD8+ T cell exhaustion in gastrointestinal cancer
Ding, J., Yang, K., Zhou, H., Huang, Y.-F., Li, H., & Zong, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1149622 · Cited by 45
Kerstein-Staehle, A., Schüler, S., Cabral-Marques, O., Fazio, J., Häsler, R., Müller, A., Pitann, S., Moosig, F., Klapa, S., Haas, C. S., et al. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.12.004 · Cited by 40
The PD-1/PD-L pathway in rheumatic diseases
Zhang, S., Wang, L., Li, M., Zhang, F., & Zeng, X. (2020) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2020.04.004 · Cited by 40
Advancing beyond the twists and turns of T cell exhaustion in cancer
van der Heide, V., Humblin, É., Vaidya, A. B., & Kamphorst, A. O. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo4997 · Cited by 41
“Supporting this conceptual framework, murine autoreactive CD8 T cells were recently found to be restrained by an exhaustion-like program under control of the inhibitory receptor LAG-3 (12), whereas the presence of an “exhausted” gene signature was predictive of a better clinical prognosis in multiple autoimmune disord…”
BackgroundT-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases
McKinney, E. F., & Smith, K. G. (2016) · Immunology & Cell Biology · doi:10.1038/icb.2016.81 · Cited by 36
Self-citationRole of Mesenchymal Stem Cells and Extracellular Vesicles in Idiopathic Pulmonary Fibrosis
Kletukhina, S. K., Mutallapova, G., Андреевна, Т. А., & Gomzikova, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911212 · Cited by 38
Toward precision manufacturing of immunogene T-cell therapies
Xu, J., Melenhorst, J. J., & Fraietta, J. A. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2017.12.007 · Cited by 38
Liu, J., Cho, Y. B., Hong, H. K., Wu, S., Ebert, P. J., Bray, S. M., Wong, S. S., Ting, J. C., Calley, J. N., Whittington, C. F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67842-5 · Cited by 38
T-cell Exhaustion in Organ Transplantation
Angeletti, A., Cantarelli, C., Riella, L. V., Fribourg, M., & Cravedi, P. (2021) · Transplantation · doi:10.1097/tp.0000000000003851 · Cited by 39
“However, in the setting of persistent antigen stimulation, effector memory T cells fail to develop properly and T cells acquire an exhausted phenotype characterized by reduced cytokine production, high and sustained expression of inhibitory receptors, and unique epigenetic, metabolic, and transcriptional signatures.(1…”
BackgroundFc Gamma Receptor IIB Deficient Mice
Ondee, T., Surawut, S., Taratummarat, S., Hirankarn, N., Palaga, T., Pisitkun, P., Pisitkun, T., & Leelahavanichkul, A. (2016) · Shock · doi:10.1097/shk.0000000000000796 · Cited by 38
“However, the immune response function becomes exhausted after the repeated/chronic infections (10, 11) or with the huge microorganism burdens (12–14).”
BackgroundImmune checkpoints in chronic obstructive pulmonary disease
Wilkinson, T. M. A. (2017) · European Respiratory Review · doi:10.1183/16000617.0045-2017 · Cited by 38
Signaling by Type I Interferons in Immune Cells: Disease Consequences
Ζαννίκου, Μ., Fish, E. N., & Platanias, L. C. (2024) · Cancers · doi:10.3390/cancers16081600 · Cited by 43
“…aberrations, less functional mitochondria, decreased cell viability and are associated with SLE (Systemic lupus erythematosus) development [147], contributing to immune imbalance, inflammation, tissue injury [148] granzyme B release, and the subsequent increase of the autoantigen load…”
BackgroundXu, X., Chen, H., Ren, Z., Xu, X., Wu, W., Yang, H., Wang, J., Zhang, Y., Zhou, Q., Li, H., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.11.005 · Cited by 44
Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users
Piepenbrink, M. S., Samuel, M., Zheng, B., Carter, B., Fucile, C., Bunce, C. A., Kiebala, M., Khan, A. A., Thakar, J., Maggirwar, S. B., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158641 · Cited by 36
“However, chronic inflammation may drive an exhausted-like immune response similar to that observed in chronic infections [85, 86], or conversely hyper-responsiveness, similar to what we observed in early-stage rheumatoid arthritis patients [28].”
ResultPPP2R2B hypermethylation causes acquired apoptosis deficiency in systemic autoimmune diseases
Madera-Salcedo, I. K., Sánchez-Hernández, B. E., Svyryd, Y., Esquivel‐Velázquez, M., Rodríguez‐Rodríguez, N., Trejo‐Zambrano, M. I., García-González, H. B., Hernández‐Molina, G., Mutchinick, O. M., Alcocer-Varela, J. C., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126457 · Cited by 37
“For example, patients with systemic lupus erythematosus (SLE) whose T cells exhibit a gene expression profile indicative of exhaustion have a better prognosis than patients with no transcriptional signs of T cell exhaustion (3, 4).”
BackgroundHöfer, A., Jonigk, D. D., Hartleben, B., Verboom, M., Hallensleben, M., Hübscher, S. G., Manns, M. P., Jaeckel, E., & Taubert, R. (2019) · Transplantation · doi:10.1097/tp.0000000000003034 · Cited by 37
Influence of immunomodulatory drugs on the gut microbiota
Cohen, I., Ruff, W. E., & Longbrake, E. E. (2021) · Translational research · doi:10.1016/j.trsl.2021.01.009 · Cited by 39
IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?
Cui, X., Liu, W., Jiang, H., Zhao, Q., Hu, Y., Tang, X., Liu, X., Dai, H., Rui, H., & Liu, B. (2024) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2024.100263 · Cited by 42
Mitochondrial Metabolism in T-Cell Exhaustion
Li, F., Yu, F., Yin, Z., & Wang, Y. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157400 · Cited by 42
“For instance, given the reduction in T cell exhaustion in autoimmunity, inducing exhaustion may serve as a therapeutic strategy for autoimmune diseases [137].”
Bianchini, S., Orabona, C., Camilloni, B., Berioli, M. G., Argentiero, A., Matino, D., Alunno, A., Albini, E., Vacca, C., Pallotta, M. T., et al. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1633877 · Cited by 37
Ormseth, M. J., Solus, J. F., Sheng, Q., Chen, S., Ye, F., Wu, Q., Oeser, A. M., Allen, R. M., Raggi, P., Vickers, K. C., et al. (2021) · Clinical Rheumatology · doi:10.1007/s10067-020-05573-8 · Cited by 36
“Concordant with this possibility, pathways related to autoimmunity including SLE B cell and T cell exhaustion [36] were among the top targets, suggesting potential overlapping pathways in atherosclerosis and autoimmune disease.”
BackgroundChan, C., Liu, I. D., Resontoc, L. P. R., Ng, K. H., Chan, Y., Lau, P. Y.-W., Than, M., Jordan, S. C., Lam, K., Yeo, W. S., et al. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11941115 · Cited by 35
“This could represent inhibition of T cell function or even a state of T cell exhaustion (32,33) that is corrected by B cell depletion.”
BackgroundFleury, M., Belkina, A. C., Proctor, E. A., Zammitti, C. A., Simms, R. W., Lauffenburger, D. A., Snyder-Cappione, J. E., Lafyatis, R., & Dooms, H. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40399 · Cited by 34
“While the expression of co-IRs, as a hallmark of Tcell exhaustion, has been associated with disease outcome in several autoimmune diseases, including lupus and type 1 diabetes (10), an extensive comparison of the expression of multiple coIRs between SSc patients and healthy subjects has not been performed.”
BackgroundT cells and cytokines in systemic sclerosis
Fuschiotti, P. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000553 · Cited by 34
Role of CD8+ T cells in crescentic glomerulonephritis
Chen, A., Lee, K., Guan, T., He, C., & Schlöndorff, D. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz043 · Cited by 35
A Human In Vitro T Cell Exhaustion Model for Assessing Immuno-Oncology Therapies
Dunsford, L. S., Thoirs, R. H., Rathbone, E. J., & Patakas, A. (2020) · Methods in pharmacology and toxicology · doi:10.1007/978-1-0716-0171-6_6 · Cited by 34
The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes
Clark, M., Kroger, C. J., Qi, K., & Tisch, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.615371 · Cited by 37
Biological impact of iberdomide in patients with active systemic lupus erythematosus
Lipsky, P. E., van Vollenhoven, R., Dörner, T., Werth, V. P., Merrill, J. T., Furie, R. A., Petronijević, M., Zamora, B. V., Majdan, M., Irazoque-Palazuelos, F. C., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2022-222212 · Cited by 35
Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
Dai, Z., Sezin, T., Chang, Y., Lee, E. Y., Wang, E. H. C., & Christiano, A. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955038 · Cited by 35
“Previous studies showed that exhausted, unresponsive CD8 T cells were associated with poor clearance of chronic viral infections as well as cancer cells, but were predictive of good prognosis in several autoimmune diseases (37).”
ResultSystems Medicine in Chronic Inflammatory Diseases
Schultze, J. L., & Rosenstiel, P. C. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.022 · Cited by 37
Learning from the nexus of autoimmunity and cancer
Mangani, D., Yang, D., & Anderson, A. C. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.022 · Cited by 33
Reyes, M., Vickers, D. A. L., Billman, K., Eisenhaure, T., Hoover, P., Browne, E. P., Rao, D. A., Hacohen, N., & Blainey, P. C. (2019) · Science Advances · doi:10.1126/sciadv.aau9223 · Cited by 35
Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling
Pagé, N., Lemeille, S., Vincenti, I., Klimek, B., Mariotte, A., Wagner, I., Liberto, G. D., Kaye, J., & Merkler, D. (2021) · Nature Communications · doi:10.1038/s41467-021-21109-3 · Cited by 36
d’Alessandro, M., Soccio, P., Bergantini, L., Cameli, P., Scioscia, G., Barbaro, M. P. F., Lacedonia, D., & Bargagli, E. (2021) · Cells · doi:10.3390/cells10051045 · Cited by 34
“An increasing trend in the number of CD8 cells expressing the activation marker CD69 h s bee demonstrated in IPF patients, suggesting possible enhancement in the number of activated T suppressor/cytotoxic cells in IPF [33,34].”
BackgroundNK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19
Bergantini, L., d’Alessandro, M., Cameli, P., Cavallaro, D., Gangi, S., Cekorja, B., Sestini, P., & Bargagli, E. (2021) · Cells · doi:10.3390/cells10113182 · Cited by 34
“In any case, there is evidence that PD-1 inhibitory signalling properties maintain an exhausted phenotype in NK cells and T cells in chronic infection and cancer [48].”
BackgroundZhong, T., Li, X., Lei, K., Tang, R., Deng, Q., Love, P. E., Zhou, Z., Zhao, B., & Li, X. (2024) · Nature Communications · doi:10.1038/s41467-024-53264-8 · Cited by 38
Exhaustion and Inflation at Antipodes of T Cell Responses to Chronic Virus Infection
Čičin‐Šain, L., & Arens, R. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.11.012 · Cited by 32
Diabetes associated with immune checkpoint inhibition: presentation and management challenges
Galligan, A., Xu, W., Fourlanos, S., Nankervis, A. J., Chiang, C. Y., Mant, A. M., Parente, P., Rischin, D., Krishnamurthy, B., Sandhu, S. K., et al. (2018) · Diabetic Medicine · doi:10.1111/dme.13762 · Cited by 33
Bates, M. A., Benninghoff, A. D., Gilley, K. N., Holian, A., Harkema, J. R., & Pestka, J. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00632 · Cited by 33
“These T cell phenotypes are associated with downregulation of the immune response and increased numbers have been associated with lupus and other autoimmune diseases (43, 44).”
Wang, S., Zissler, U. M., Büttner, M., Heine, S., Heldner, A., Kotz, S., Pechtold, L., Kau, J., Plaschke, M., Ullmann, J. T., et al. (2021) · Allergy · doi:10.1111/all.14896 · Cited by 37
Recent advances in understanding type 1 diabetes
Christoffersson, G., Rodriguez-Calvo, T., & von Herrath, M. (2016) · F1000Research · doi:10.12688/f1000research.7356.1 · Cited by 32
Ghadiri, M., Rezk, A., Li, R., Evans, A., Giacomini, P. S., Barnett, M. H., Antel, J. P., & Bar‐Or, A. (2020) · Scientific Reports · doi:10.1038/s41598-019-57114-2 · Cited by 32
Ye, Y., Zhang, X., Li, T., Ma, J., Wang, R., Wu, C., Wang, R., Bao, C., Ye, S., Shen, N., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42264 · Cited by 32
“00 Female 59 (72) 24 (71) 35 (73) Male 23 (28) 10 (29) 13 (27) Age, mean ± SD years 48.”
Imaging of cerebrovascular complications of infection
Shen, G., Shen, X., Pu, W., Zhang, G., Lerner, A., & Gao, B. (2018) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims.2018.11.08 · Cited by 31
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2
Jo, Y., Sim, H.-I., Yun, B., Park, Y., & Jin, H. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01317-9 · Cited by 31
Kim, K. S., Sekar, R. R., Patil, D. H., Dimarco, M. A., Kissick, H. T., Bilen, M. A., Osunkoya, A. O., & Master, V. A. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1413519 · Cited by 31
“with good clinical outcome in autoimmune and inflammatory diseases and poor outcome/response to therapy in chronic viral infection and vaccination.(40)”
BackgroundHoover, P., Der, E. B., Berthier, C. C., Arazi, A., Lederer, J. A., James, J. A., Buyon, J. P., Petri, M., Belmont, M. H., Izmirly, P., et al. (2019) · Arthritis Care & Research · doi:10.1002/acr.24066 · Cited by 30
“A CD8 T cell exhaustion signature in the peripheral blood is associated with a better overall prognosis of patients with lupus but not with disease activity per se (10).”
BackgroundLahore, G. F., Förster, M., Johannesson, M., Sabatier, P., Lönnblom, E., Aoun, M., He, Y., Nandakumar, K. S., Zubarev, R. A., & Holmdahl, R. (2021) · Nature Communications · doi:10.1038/s41467-021-25828-5 · Cited by 31
Vitamin D increases programmed death receptor-1 expression in Crohn’s disease
Bendix, M., Greisen, S. R., Dige, A. K., Hvas, C. L., Fuglsang, N. F. B., Jørgensen, S. P., Dahlerup, J. F., Deleuran, B. W., & Agnholt, J. S. (2017) · Oncotarget · doi:10.18632/oncotarget.15489 · Cited by 32
“PD-1 expression is increased in exhausted T cells, which are identified in patients with chronic infections and autoimmune diseases [20-22].”
BackgroundZhong, H., Huan, X., Zhao, R., Su, M., Yan, C., Song, J., Xi, J., Zhao, C., Luo, F.-F., & Luo, S.-S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04421-y · Cited by 28
“CD8 + T cell exhaustion was found to be associated with a good outcome in autoimmune diseases [64].”
BackgroundChen, Z., Zhu, Z., Hu, T., Yao, C., & Wu, T. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01378-4 · Cited by 37
“Exhaustion limits immuno-pathology by dampening autoreactive CD8 T-cell responses, acting as a form of peripheral tolerance once self-reactivity is established [27, 30].”
Future Therapy for Hepatitis B Virus: Role of Immunomodulators
Pham, E. A., Perumpail, R. B., Fram, B. J., Glenn, J. S., Ahmed, A., & Gish, R. G. (2016) · Current Hepatology Reports · doi:10.1007/s11901-016-0315-9 · Cited by 30
Stefanski, A., Wiedemann, A., Reiter, K., Hiepe, F., Lino, A. C., & Dörner, T. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40897 · Cited by 30
“For example, other than in chronic infections, exhausted CD8+ T cells seem to predict a favorable prognosis in autoimmune diseases such as SLE (15).”
BackgroundReview article: the genetics of the human leucocyte antigen region in inflammatory bowel disease
Ashton, J. J., Latham, K., Beattie, R. M., & Ennis, S. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15485 · Cited by 30
Enforcing the checkpoints: harnessing T-cell exhaustion for therapy of T1D
Linsley, P. S., & Long, S. A. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000488 · Cited by 30
Checkpoint-based immunotherapy for autoimmune diseases – Opportunities and challenges
He, X.-S., Gershwin, M. E., & Ansari, A. A. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.02.004 · Cited by 29
Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells
Schluck, M., Hammink, R., Figdor, C. G., Verdoes, M., & Weiden, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00931 · Cited by 30
“An alternative strategy to prevent T cell exhaustion could be to provide co-stimulation with an αCD2 antibody (103).”
BackgroundChen, J., Qian, X., He, Y., Han, X., & Pan, Y. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28948 · Cited by 29
Fujiogi, M., Raita, Y., Pérez‐Losada, M., Freishtat, R. J., Celedon, J. C., Mansbach, J. M., Piedra, P. A., Zhu, Z., Camargo, C. A., & Hasegawa, K. (2022) · Nature Communications · doi:10.1038/s41467-022-32323-y · Cited by 31
“Lifetime history of systemic antibiotic use 79 (32)”
BackgroundLevite, M. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.357903 · Cited by 29
“…poor memory recall; homeostatic self-renewal and proliferation; and distinct transcriptional and epigenetic programs (Crespo et al., 2013; McKinney et al., 2015; McKinney and Smith, 2016; Hashimoto et al., 2018; Saeidi et al., 2018; Stelekati et al., 2018; Kurachi, 2019; McLane et al.,…”
BackgroundInfluentialMeng, G., & Mei, H. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00101 · Cited by 28
“Another way is to associate the subnetwork expression to disease progresses or clinical traits, which can uncover the regulatory components involved in the dysregulation of diseases (McKinney et al., 2015).”
BackgroundAlRumayyan, N., Slauenwhite, D., McAlpine, S. M., Roberts, S., Issekutz, T. B., Huber, A. M., Liu, Z., & Dérfalvi, B. (2022) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-022-00658-2 · Cited by 28
“T cell cytokine responses in both patients were normal with the exception of elevated proportions of IL-17+ CD8+ TEM cells [35].”
BackgroundLawton, M. L., Inge, M. M., Blum, B. C., Smith-Mahoney, E. L., Bolzan, D., Lin, W., McConney, C., Porter, J., Moore, J., Youssef, A., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002943 · Cited by 25
“…opted to probe both KAT2B, a histone acetyltransferase known to associate with p300 that has been implicated as a marker in T-cell exhaustion [109,110], and a mixture of class I HDACs (HDAC1/2/3), which have also been linked to T-cell exhaustion [111–113] and were connected in our p300-centered…”
Exhaustion of CD39-Expressing CD8+ T Cells in Crohn’s Disease Is Linked to Clinical Outcome
Globig, A.-M., Mayer, L., Heeg, M., Andrieux, G., Ku, M., Otto-Mora, P., Hipp, A. V., Zoldan, K., Pattekar, A., Rana, N., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.045 · Cited by 30
Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming
Alvanou, M., Lysandrou, M., Christofi, P., Psatha, N., Spyridonidis, A., Παπαδοπούλου, Α., & Yannaki, E. (2023) · Cancers · doi:10.3390/cancers15071935 · Cited by 28
Seki, N., Tsujimoto, H., Tanemura, S., Kojima, S., Miyoshi, F., Kikuchi, J., Saito, S., Akiyama, M., Sugahara, K., Yoshimoto, K., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-05989-x · Cited by 29
“Furthermore, it has been shown that in chronic infections, cancer and autoimmune diseases, persistent antigen stimulation under suboptimal conditions can lead to the induction of T-cell exhaustion 30 – 33 .”
Ondee, T., Jaroonwitchawan, T., Pisitkun, T., Gillen, J., Nita‐Lazar, A., Leelahavanichkul, A., & Somparn, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061354 · Cited by 26
“Indeed, the immune exhaustion after repeatedor high-stimulation by pathogens in chronic infection or sepsis, respectively, is well-known [5,6].”
Background4‐1BB costimulation promotes bystander activation of human CD8 T cells
Reithofer, M., Rosskopf, S., Leitner, J. M., Battin, C., Bohle, B., Steinberger, P., & Jahn‐Schmid, B. (2020) · European Journal of Immunology · doi:10.1002/eji.202048762 · Cited by 26
L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapy
Hayashi, K., & Anzai, N. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.09.006 · Cited by 29
Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy
Shen, P., Deng, X., Hu, Z., Chen, Z., Huang, Y., Wang, X., Qin, K., Huang, Y., Ba, X., Yan, J., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.762247 · Cited by 27
Gamerith, G., Mildner, F., Merkel, P. A., Harris, K. M., Cooney, L., Lim, N., Spiera, R., Seo, P., Langford, C. A., Hoffman, G. S., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-222479 · Cited by 26
Doan-Ngoc, T.-M., Tilly, G., Danger, R., Bonizec, O., Masset, C., Guérif, P., Bruneau, S., Glémain, A., Harb, J., Cadoux, M., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022030286 · Cited by 26
Yan, C., Ma, X., Guo, Z., Wei, X., Han, D., Zhang, T., Chen, X., Cao, F., Dong, J., Zhao, G., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2025668 · Cited by 25
Readapting the adaptive immune response – therapeutic strategies for atherosclerosis
Sage, A. P., & Mallat, Z. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13700 · Cited by 24
“High PD-1 expression on T cells can also be associated with anergic or exhausted T cells in chronic inflammation in humans (McKinney et al., 2015) and may mark a pathogenic subset of T cells refractory to normal inhibitory signals.”
BackgroundSchrezenmeier, E. V., Weißenberg, S. Y., Stefanski, A., Szelinski, F., Wiedemann, A., Lino, A. C., & Dörner, T. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000576 · Cited by 26
Treatment of natalizumab‐associated PML with filgrastim
Stefoski, D., Balabanov, R. D., Waheed, R., Ko, M., Koralnik, I. J., & Morales, F. S. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.776 · Cited by 25
Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance
Martinov, T., & Fife, B. T. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14106 · Cited by 28
Heterogeneity and clonality of kidney-infiltrating T cells in murine lupus nephritis
Smita, S., Chikina, M. D., Shlomchik, M. J., & Tilstra, J. S. (2022) · JCI Insight · doi:10.1172/jci.insight.156048 · Cited by 24
Shi, M., Wang, Y., Zhang, H., Ling, Z., Chen, X., Wang, C., Liu, J., & Ma, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1203062 · Cited by 24
“CD8+ T cells might present with exhaustion markers in some patients with autoimmune-related kidney diseases, like SLE and IgAN (19, 20).”
New Therapeutic Targets in Antineutrophil Cytoplasm Antibody–Associated Vasculitis
Prendecki, M. F., & McAdoo, S. P. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41407 · Cited by 25
“cell phenotype has been shown to correlate with a reduced risk of disease relapse (30).”
BackgroundImmune Modulation in Lung Cancer: Current Concepts and Future Strategies
Gaissmaier, L., & Christopoulos, P. (2020) · Respiration · doi:10.1159/000510385 · Cited by 24
Hobit and human effector T‐cell differentiation: The beginning of a long journey
Braun, J., Frentsch, M., & Thiel, A. (2015) · European Journal of Immunology · doi:10.1002/eji.201545959 · Cited by 24
Czaja, A. J. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1453356 · Cited by 25
“tion [115], and manipulations that suppress the activation and proliferation of CD4 T cells, block CD2 signaling, and inhibit”
BackgroundVasculitis Pathogenesis: Can We Talk About Precision Medicine?
Özen, S., & Batu, E. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01892 · Cited by 24
“In another study of the same group on gene-expression biomarkers, they demonstrated an association between T cell exhaustion and poor prognosis in AAV and suggested that this process could be targeted in AAV treatment (100).”
Qin, Y., Chen, S., Gui, Q., Zhang, T., Li, Y., Du, Z., Lv, Y., Du, X., Hu, Y., & Liu, Z. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1372861 · Cited by 24
Faliti, C. E., Van, T. T. P., Anam, F. A., Cheedarla, N., Williams, M. E., Mishra, A. K., Usman, S. Y., Woodruff, M. C., Kraker, G., Runnstrom, M. C., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-02010-9 · Cited by 23
Dysregulated T cells in multiple sclerosis
Chihara, N. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12438 · Cited by 23
“might be largely distinct from the initial factors predisposing to broken self tolerance.(1) MS is an autoimmune disorder characterized by”
BackgroundNovel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis
Sciveres, M., Nastasio, S., & Maggiore, G. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00382 · Cited by 24
“PD-1 is also found to be increased in exhausted T cells (51).”
BackgroundLevite, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.617658 · Cited by 23
Pan, M., Zhao, H., Jin, R., Leung, P. S. C., & Shuai, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1156212 · Cited by 24
The role of MDA5 in the development of autoimmune disease
Sadler, A. J. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0617-223r · Cited by 23
“However, the presence of exhausted T cells in patients with autoimmune diseases correlates with a more favorable prognosis [68].”
Mijnheer, G., & van Wijk, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00940 · Cited by 24
“Previous observations from peripheral blood derived CD8 Tcells show that the transcriptional signature reflecting exhaustion is associated with poor clearance of chronic viral infection, but conversely predicts better prognosis in multiple auto-immune diseases, including SLE (49).”
BackgroundClinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients
Hu, X., Shen, C., Meng, T., Ooi, J. D., Eggenhuizen, P. J., Zhou, Y.-O., Luo, H., Chen, J.-B., Lin, W., Gong, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.991469 · Cited by 22
“We assume that one probable reason is that patients with lower lymphocyte count might have higher proportions of nonexhausted autoreactive T cells which drive kidney injury in patients with DPPs, as a previous study has shown that CD8 T cell exhaustion could predict a favorable outcome in multisystem autoimmune and in…”
ResultTranscriptomic studies of systemic lupus erythematosus
Nakano, M., Iwasaki, Y., & Fujio, K. (2021) · Inflammation and Regeneration · doi:10.1186/s41232-021-00161-y · Cited by 20
“[39] 2015 23 adults CD4+ T cells, CD8+ T cells Microarray The exhaustion signature in CD8 T cells, which was associated with poor outcomes in patients with viral infections, was correlated with a lower risk of disease relapse in AAV and SLE patients.”
BackgroundHonan, A. M., & Chen, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.658984 · Cited by 21
“This was seen in antibody associated vasculitis (AAV), IBD, and systemic lupus erythematosus (SLE) (McKinney et al., 2015).”
BackgroundMiao, Y., Quan, W., Tang, X., Shi, W., Li, Q., Li, R. J., Wang, J., Gan, J., Dong, X., Liang, H., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.89376 · Cited by 23
“Disease activity in antinuclear cytoplasmic antibody (ANCA)-related vasculitis and SLE could be linked to T-cell exhaustion, as an instance [209].”
Metadata
- Authors
- McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A., & Smith, K. G. C.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- McKinney, Eoin F.
- Smith, Kenneth G. C.
- Venue
- Nature
- Published
- 2015-06-29
- Volume
- 523
- Issue
- 7562
- Pages
- 612-616
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4623162
- OpenAlex
- W2103056503
- Cited by
- 685
- References
- 56
- Citations by year
- 2026: 45 · 2025: 54 · 2024: 82 · 2023: 45 · 2022: 81 · 2021: 65 · 2020: 73 · 2019: 74 · 2018: 65 · 2017: 48 · 2016: 40 · 2015: 10
- FWCI
- 26.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (083650/Z/07/Z, 104064, 104064/Z/14/Z, 100140, 079895/Z/06/Z, 083650, 079895, 100140/Z/12/Z, 094227, 094227/Z/10/Z, 079895/Z/06/B)
- Medical Research Council (MR/L019027/1)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- T cell exhaustion, CD8+ T cells, PD-1, chronic viral infection, autoimmune disease, inflammatory diseases, prognosis, hepatitis C virus, vaccine response, type 1 diabetes, systemic lupus erythematosus, antineutrophil cytoplasmic antibody-associated vasculitis, idiopathic pulmonary fibrosis, dengue hemorrhagic fever, gene expression signatures, autoreactivity
- MeSH terms
- Animals, Autoimmune Diseases, Humans, Infections, Inflammation, Lupus Erythematosus, Systemic, Phenotype, Receptors, Antigen, T-Cell, Inflammatory Bowel Diseases, CD4-Positive T-Lymphocytes, Autoimmunity, CD8-Positive T-Lymphocytes, CD2 Antigens, Receptors, Interleukin-7, Mice, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Transcriptome, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review